Activated peritoneal cavity B-1a cells possess regulatory B cell properties

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Margry, Bram ^a   Kersemakers, Saskia C W ^a   Hoek, Aad ^a   Arkesteijn, Ger J A ^a   Wieland, Willemien H ^a   Van Eden, Willem ^a   Broere, Femke ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; B 1A CELL; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNOREGULATION; IN VITRO STUDY; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PERITONEAL CAVITY;

ANIMALS; ANTIBODIES; ANTIGENS, CD40; B-LYMPHOCYTES, REGULATORY; CD4-POSITIVE T-LYMPHOCYTES; COCULTURE TECHNIQUES; FEMALE; IMMUNITY, INNATE; IMMUNOGLOBULIN M; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; PERITONEAL CAVITY; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84895816260     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088869     Document Type: Article

References (42)

1. Mauri C, Bosma A (2012) Immune regulatory function of B cells. Annu Rev Immunol 30: 221-241.
2. Fillatreau S, Gray D, Anderton SM (2008) Not always the bad guys: B cells as regulators of autoimmune pathology. Nat Rev Immunol 8: 391-397. (Pubitemid 351595221)
3. DiLillo DJ, Matsushita T, Tedder TF (2010) B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann N Y Acad Sci 1183: 38-57.
4. Evans JG, Chavez-Rueda KA, Eddaoudi A, Meyer-Bahlburg A, Rawlings DJ, et al. (2007) Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol 178: 7868-7878. (Pubitemid 46898059)
5. Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, et al. (2008) A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28: 639-650. (Pubitemid 351636247)
6. Baumgarth N (2011) The double life of a B-1 cell: Self-reactivity selects for protective effector functions. Nat Rev Immunol 11: 34-46.
7. Sindhava VJ, Bondada S (2012) Multiple regulatory mechanisms control B-1 B cell activation. Front Immunol 3: 372.
8. Suzuki K, Maruya M, Kawamoto S, Fagarasan S (2010) Roles of B-1 and B-2 cells in innate and acquired IgA-mediated immunity. Immunol Rev 237: 180-190.
9. Yoshizaki A, Miyagaki T, DiLillo DJ, Matsushita T, Horikawa M, et al. (2012) Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 491: 264-268.
10. Lampropoulou V, Hoehlig K, Roch T, Neves P, Gómez EC, et al. (2008) TLR-activated B cells suppress T cell-mediated autoimmunity. The Journal of Immunology 180: 4763-4773.
11. Horikawa M, Minard-Colin V, Matsushita T, Tedder TF (2011) Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice. J Clin Invest 121: 4268-4280.
12. Yanaba K, Bouaziz JD, Matsushita T, Tsubata T, Tedder TF (2009) The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol 182: 7459-7472.
13. Miles K, Heaney J, Sibinska Z, Salter D, Savill J, et al. (2012) A tolerogenic role for toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells. Proceedings of the National Academy of Sciences 109: 887-892.
14. Mauri C, Gray D, Mushtaq N, Londei M (2003) Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 197: 489-501. (Pubitemid 36278604)
15. Blair PA, Chavez-Rueda KA, Evans JG, Shlomchik MJ, Eddaoudi A, et al. (2009) Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J Immunol 182: 3492-3502.
16. Poe JC, Smith SH, Haas KM, Yanaba K, Tsubata T, et al. (2011) Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice. PLoS One 6: e22464.
17. Matsushita T, Horikawa M, Iwata Y, Tedder TF (2010) Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J Immunol 185: 2240-2252.
18. Carter NA, Vasconcellos R, Rosser EC, Tulone C, Muñoz-Suano A, et al. (2011) Mice lacking endogenous IL-10-Producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. The Journal of Immunology 186: 5569-5579.
19. Amu S, Saunders SP, Kronenberg M, Mangan NE, Atzberger A, et al. (2010) Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J Allergy Clin Immunol 125: 1114-1124.e8.
20. Gray M, Miles K, Salter D, Gray D, Savill J (2007) Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc Natl Acad Sci U S A 104: 14080-14085. (Pubitemid 350003338)
21. Carter N, Rosser E, Mauri C (2012) Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis. Arthritis Research & Therapy 14: R32.
22. van dV, Labuda LA, Ozir-Fazalalikhan A, Lievers E, Gloudemans AK, et al. (2012) Schistosomes induce regulatory features in human and mouse CD1dhi B cells: Inhibition of allergic inflammation by IL-10 and regulatory T cells. PLoS ONE 7: e30883.
23. Yang M, Sun L, Wang S, Ko K, Xu H, et al. (2010) Cutting edge: Novel function of B cell-activating factor in the induction of IL-10-Producing regulatory B cells. The Journal of Immunology 184: 3321-3325.
24. DiLillo DJ, Weinberg JB, Yoshizaki A, Horikawa M, Bryant JM, et al. (2013) Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function. Leukemia 27: 170-182.
25. Iwata Y, Matsushita T, Horikawa M, DiLillo DJ, Yanaba K, et al. (2011) Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 117: 530-541.
26. Blair PA, Noreña LY, Flores-Borja F, Rawlings DJ, Isenberg DA, et al. (2010) CD19+CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 32: 129-140.
27. Flores-Borja F, Bosma A, Ng D, Reddy V, Ehrenstein MR, et al. (2013) CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Science Translational Medicine 5: 173ra23-173ra23.
28. Saraiva M, O'Garra A (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10: 170-181.
29. Barr TA, Shen P, Brown S, Lampropoulou V, Roch T, et al. (2012) B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. The Journal of Experimental Medicine 209: 1001-1010.
30. Margry B, Wieland WH, van Kooten PJ, van Eden W, Broere F (2013) Peritoneal cavity B-1a cells promote peripheral CD4 + T-cell activation. Eur J Immunol 43: 2317-2326.
31. Silverman GJ, Vas J, Gronwall C (2013) Protective autoantibodies in the rheumatic diseases: Lessons for therapy. Nat Rev Rheumatol 9: 291-300.
32. Mohan C, Morel L, Yang P, Wakeland EK (1998) Accumulation of splenic B1a cells with potent antigen-presenting capability in NZM2410 lupus-prone mice. Arthritis Rheum 41: 1652-1662. 2-W.
33. Gray D, Gray M, Barr T (2007) Innate responses of B cells. Eur J Immunol 37: 3304-3310.
34. O'Neill SK, Cao Y, Hamel KM, Doodes PD, Hutas G, et al. (2007) Expression of CD80/86 on B cells is essential for autoreactive T cell activation and the development of arthritis. The Journal of Immunology 179: 5109-5116.
35. Maseda D, Candando KM, Smith SH, Kalampokis I, Weaver CT, et al. (2013) Peritoneal cavity regulatory B cells (B10 cells) modulate IFN-gamma+CD4+ T cell numbers during colitis development in mice. J Immunol 191: 2780-2795.
36. Koni PA, Bolduc A, Takezaki M, Ametani Y, Huang L, et al. (2013) Constitutively CD40-activated B cells regulate CD8 T cell inflammatory response by IL-10 induction. J Immunol 190: 3189-3196.
37. Kretschmer B, Kühl S, Fleischer B, Breloer M (2011) Activated T cells induce rapid CD83 expression on B cells by engagement of CD40. Immunol Lett 136: 221-227.
38. Yang Y, Tung JW, Ghosn EEB, Herzenberg LA, Herzenberg LA (2007) Division and differentiation of natural antibody-producing cells in mouse spleen. Proc Natl Acad Sci U S A 104: 4542-4546. (Pubitemid 47186261)
39. Palos MC, Azevedo MC, Thies FG, Osugui L, Alvares AM, et al. (2012) Different inflammatory stimuli in the footpad of mice influence the kinetics of resident peritoneal cells. Inflamm Res 61: 1187-1194.
40. Velupillai P, Secor WE, Horauf AM, Harn DA (1997) B-1 cell (CD5 +B220+) outgrowth in murine schistosomiasis is genetically restricted and is largely due to activation by polylactosamine sugars. J Immunol 158: 338-344. (Pubitemid 127483874)
41. Nakashima H, Hamaguchi Y, Watanabe R, Ishiura N, Kuwano Y, et al. (2010) CD22 expression mediates the regulatory functions of peritoneal B-1a cells during the remission phase of contact hypersensitivity reactions. J Immunol 184: 4637-4645.
42. Shimomura Y, Mizoguchi E, Sugimoto K, Kibe R, Benno Y, et al. (2008) Regulatory role of B-1 B cells in chronic colitis. Int Immunol 20: 729-737. (Pubitemid 351791517)